Richard Pzena's top holdings (July 2026) include Humana Inc. (HUM), a healthcare enterprise primarily focused on providing various insurance products and health and wellness services.

Richard Pzena is the founder and Chief Investment Officer of Pzena Investment Management, an investment firm headquartered in New York. He manages the firm's fundamental value investment strategy, which focuses on identifying companies that are trading at a discount to their long-term earnings power.

Humana Inc. (HUM)

Humana operates as a health and well-being company, offering medical and supplemental benefit plans to individuals and employer groups. The company maintains a significant presence in the Medicare Advantage market and operates healthcare services through its CenterWell brand. Humana Inc. has a market capitalization of $46.08B, with Richard Pzena's position currently valued at $2.17B. Analysts have set a price target of $286.5 for the company, while its discounted cash flow analysis suggests a value of $515.21 per share.

Here's an overview of Richard Pzena's trades in Humana Inc.:

Magna International Inc. (MGA)

Magna International is a global automotive supplier that designs, develops, and manufactures components and complete vehicles for original equipment manufacturers. Its operations encompass body exteriors, power and vision technologies, and seating systems. The company's market cap stands at $17.57B, while the current value of Richard Pzena's holding is $1.66B. A price target of $66.0 has been issued by analysts, and the discounted cash flow value is calculated at $75.98.

Here's an overview of Richard Pzena's trades in Magna International Inc.:

CVS Health Corp (CVS)

CVS Health is an integrated healthcare company that operates retail pharmacies, pharmacy benefit management services, and health insurance through its Aetna division. The company's extensive network includes thousands of retail locations and walk-in clinics across the United States. This holding in Richard Pzena's portfolio is currently worth $1.42B, supporting a company with a market capitalization of $133.13B. The analyst price target for CVS stands at $104.93, with a discounted cash flow value of $270.52 per share.

Here's an overview of Richard Pzena's trades in CVS Health Corp:

Baxter International Inc. (BAX)

Baxter International focuses on providing a broad portfolio of essential healthcare products including solutions for kidney care, hospital products, and surgical tools. The company serves patients and healthcare professionals in more than 100 countries globally. Baxter International Inc. holds a market cap of $11.38B, and the current value of Richard Pzena's position is $1.38B. Market analysts have established a price target of $27.0, and the discounted cash flow model indicates a value of $33.0.

Here's an overview of Richard Pzena's trades in Baxter International Inc.:

UBS Group AG (UBS)

UBS Group AG is a multinational investment bank and financial services company founded and based in Switzerland. It provides wealth management, asset management, and investment banking services to private, institutional, and corporate clients worldwide. The position is currently valued at $1.32B within a company that has a market capitalization of $160.91B. The company's discounted cash flow analysis suggests a value of $83.28 per share.

Here's an overview of Richard Pzena's trades in UBS Group AG: